Caldwell Trust’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-80
Closed -$637 762
2025
Q1
$637 Hold
80
﹤0.01% 743
2024
Q4
$727 Hold
80
﹤0.01% 704
2024
Q3
$734 Hold
80
﹤0.01% 693
2024
Q2
$782 Sell
80
-800
-91% -$9.76K ﹤0.01% 684
2024
Q1
$13.3K Buy
880
+800
+1,000% +$14.5K ﹤0.01% 598
2023
Q4
$1.72K Hold
80
﹤0.01% 686
2023
Q3
$1.49K Hold
80
﹤0.01% 690
2023
Q2
$2.03K Hold
80
﹤0.01% 719
2023
Q1
$2.07K Hold
80
﹤0.01% 704
2022
Q4
$1.89K Hold
80
﹤0.01% 701
2022
Q3
$2.03K Sell
80
-279
-78% -$9.79K ﹤0.01% 698
2022
Q2
$11.9K Hold
359
﹤0.01% 606
2022
Q1
$25.9K Sell
359
-810
-69% -$58.4K ﹤0.01% 537
2021
Q4
$107K Sell
1,169
-685
-37% -$81.9K 0.01% 367
2021
Q3
$235K Sell
1,854
-261
-12% -$38K 0.03% 255
2021
Q2
$352K Sell
2,115
-172
-8% -$27.9K 0.05% 226
2021
Q1
$416K Buy
2,287
+1,262
+123% +$293K 0.06% 198
2020
Q4
$205K Buy
+1,025
New +$208K 0.03% 252

Other funds holding TDOC

Caldwell Trust's TDOC Position: Q2 2025 in Review

Caldwell Trust sold out of Teladoc Health (TDOC) in Q2 2025, closing a stake of 80 shares — an estimated $637 sold.

Caldwell Trust first reported a position in TDOC in Q4 2020 and held it in 18 quarters. The position peaked at $416K in Q1 2021. 359 funds tracked by Wall St. Rank hold TDOC as of Q2 2025.

  • Caldwell Trust reported no remaining Teladoc Health position as of Q2 2025 after selling out during the quarter.
  • Caldwell Trust sold 80 Teladoc Health shares in Q2 2025, an estimated $637.
  • Caldwell Trust first reported a position in Teladoc Health in Q4 2020 and held it in 18 quarters.
  • Caldwell Trust's Teladoc Health position peaked at $416K in Q1 2021.
  • 359 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2025.

Based on Caldwell Trust's 13F filing for Q2 2025, filed 22 Sep 2025.